+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Acute Spinal Cord Injury Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767506
  • Report
  • April 2019
  • Region: Global
  • 59 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Acorda Therapeutics Inc
  • Allergan Plc
  • Amgen Inc
  • AOSpine International
  • BioAxone BioSciences Inc
  • CJ CheilJedang Corp
  • MORE
The global clinical trial report- “2019 Acute Spinal Cord Injury Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Acute Spinal Cord Injury. It presents in-depth analysis of Acute Spinal Cord Injury clinical trials across markets and companies. The research work is for providing complete understanding into trends in Acute Spinal Cord Injury.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Acute Spinal Cord Injury clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Acute Spinal Cord Injury

The research work is prepared through extensive and continuous research on Acute Spinal Cord Injury trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Acute Spinal Cord Injury patients are identified
  • The report includes panorama of Acute Spinal Cord Injury clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Acute Spinal Cord Injury clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Acorda Therapeutics Inc
  • Allergan Plc
  • Amgen Inc
  • AOSpine International
  • BioAxone BioSciences Inc
  • CJ CheilJedang Corp
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Acute Spinal Cord Injury Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Acute Spinal Cord Injury Clinical Trials by Region
2.2.2 Average Enrollment of Acute Spinal Cord Injury Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Acute Spinal Cord Injury Treatment, 2019

3. Region wise Acute Spinal Cord Injury Clinical Trials
3.1 Asia Pacific Acute Spinal Cord Injury Clinical Trials by Country
3.2 Europe Acute Spinal Cord Injury Clinical Trials by Country
3.3 North America Acute Spinal Cord Injury Clinical Trials by Country
3.4 Middle East and Africa Acute Spinal Cord Injury Clinical Trials by Country
3.5 South and Central America Acute Spinal Cord Injury Clinical Trials by Country

4. Acute Spinal Cord Injury Clinical Trial Trends
4.1 Start Year wise Acute Spinal Cord Injury Clinical Trials
4.2 Phase wise Acute Spinal Cord Injury Clinical Trials
4.3 Trial Status wise Acute Spinal Cord Injury Clinical Trials
4.4 Trial Type wise Acute Spinal Cord Injury Clinical Trials

5. Acute Spinal Cord Injury Average Enrollment Trends
5.1 Average Enrollment in Acute Spinal Cord Injury Trials by Year
5.2 Average Enrollment in Acute Spinal Cord Injury Trials by Phase
5.3 Average Enrollment in Acute Spinal Cord Injury Trials by Status
5.4 Average Enrollment in Acute Spinal Cord Injury Trials by Type of Trial

6. Companies Participating in Acute Spinal Cord Injury Clinical Trials
6.1 Acute Spinal Cord Injury Trials by Sponsor Type
6.2 Acute Spinal Cord Injury Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Acute Spinal Cord Injury Trials- Phase 1
7.2 Acute Spinal Cord Injury Trials- Phase 2
7.3 Acute Spinal Cord Injury Trials- Phase 3
7.4 Acute Spinal Cord Injury Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Acute Spinal Cord Injury Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Acute Spinal Cord Injury Clinical Trials and Enrolment
Figure 5: Europe - Country wise Acute Spinal Cord Injury Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Acute Spinal Cord Injury Clinical Trials and Enrolment
Figure 7: North America - Country wise Acute Spinal Cord Injury Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Acute Spinal Cord Injury Clinical Trials and Enrolment
Figure 9: Acute Spinal Cord Injury Clinical Trials by Phase
Figure 10: Acute Spinal Cord Injury Clinical Trials by Trial Status
Figure 11: Acute Spinal Cord Injury Clinical Trials by Type
Figure 12: Acute Spinal Cord Injury Clinical Trials by Sponsor Type
Figure 13: Acute Spinal Cord Injury Clinical Trials by Leading Sponsors
Figure 14: Acute Spinal Cord Injury Average Enrollment by Phase
Figure 15: Acute Spinal Cord Injury Average Enrollment by Trial Status
Figure 16: Acute Spinal Cord Injury Average Enrollment by Type
Figure 17: Acute Spinal Cord Injury- Average Enrolment by Type of Sponsors
Figure 18: Acute Spinal Cord Injury- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Acute Spinal Cord Injury Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Acute Spinal Cord Injury Clinical Trials and Enrolment
Table 5: Europe - Country wise Acute Spinal Cord Injury Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Acute Spinal Cord Injury Clinical Trials and Enrolment
Table 7: North America - Country wise Acute Spinal Cord Injury Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Acute Spinal Cord Injury Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Acute Spinal Cord Injury Average Enrollment by Phase
Table 15: Acute Spinal Cord Injury Average Enrollment by Trial Status
Table 16: Acute Spinal Cord Injury Average Enrollment by Type
Table 17: Acute Spinal Cord Injury- Average Enrolment by Type of Sponsors
Table 18: Acute Spinal Cord Injury- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Acorda Therapeutics Inc
  • Allergan Plc
  • Amgen Inc
  • AOSpine International
  • BioAxone BioSciences Inc
  • CJ CheilJedang Corp
  • CSL Ltd
  • Daiichi Sankyo Co Ltd
  • DP Clinical Inc
  • Novartis AG
Note: Product cover images may vary from those shown
Adroll
adroll